|
1
|
Znaor A, Lortet-Tieulent J, Laversanne M,
Jemal A and Bray F: International variations and trends in renal
cell carcinoma incidence and mortality. Eur Urol. 67:519–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheville JC, Lohse CM, Zincke H, Weaver AL
and Blute ML: Comparisons of outcome and prognostic features among
histologic subtypes of renal cell carcinoma. Am J Surg Pathol.
27:612–624. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singer EA, Gupta GN and Srinivasan R:
Update on targeted therapies for clear cell renal cell carcinoma.
Curr Opin Oncol. 23:283–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janzen NK, Kim HL, Figlin RA and
Belldegrun AS: Surveillance after radical or partial nephrectomy
for localized renal cell carcinoma and management of recurrent
disease. Urol Clin North Am. 30:843–852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amato RJ: Chemotherapy for renal cell
carcinoma. Semin Oncol. 27:177–186. 2000.PubMed/NCBI
|
|
6
|
Hsu RJ, Ho JY, Cha TL, Yu DS, Wu CL, Huang
WP, Chu P, Chen YH, Chen JT and Yu CP: WNT10A plays an oncogenic
role in renal cell carcinoma by activating WNT/β-catenin pathway.
PLoS One. 7:e476492012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gurib-Fakim A: Medicinal plants:
Traditions of yesterday and drugs of tomorrow. Mol Aspects Med.
27:1–93. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cragg GM and Newman DJ: Natural products:
A continuing source of novel drug leads. Biochim Biophys Acta.
1830:3670–3695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tutton PJ and Barkla DH: Influence of
prostaglandin analogues on epithelial cell proliferation and
xenograft growth. Br J Cancer. 41:47–51. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stone OJ: Cancer resistance,
carcinogenesis and ground substance viscosity. Med Hypotheses.
20:117–124. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sirtori CR: Aescin: Pharmacology,
pharmacokinetics and therapeutic profile. Pharmacol Res.
44:183–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu F, Hou Y, Jiang W, Wang R and Liu K:
Escin: Inhibiting inflammation and promoting gastrointestinal
transit to attenuate formation of postoperative adhesions. World J
Surg. 29:1614–1620. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diehm C, Trampisch HJ, Lange S and Schmidt
C: Comparison of leg compression stocking and oral horse-chestnut
seed extract therapy in patients with chronic venous insufficiency.
Lancet. 347:292–294. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bielanski TE and Piotrowski ZH:
Horse-chestnut seed extract for chronic venous insufficiency. J Fam
Pract. 48:171–172. 1999.PubMed/NCBI
|
|
15
|
Rothkopf M and Vogel G: New findings on
the efficacy and mode of action of the horse chestnut saponin
escin. Arzneimittelforschung. 26:225–235. 1976.(In German).
PubMed/NCBI
|
|
16
|
Matsuda H, Li Y, Murakami T, Ninomiya K,
Yamahara J and Yoshikawa M: Effects of escins Ia, Ib, IIa, and IIb
from horse chestnut, the seeds of Aesculus hippocastanum L., on
acute inflammation in animals. Biol Pharm Bull. 20:1092–1095. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang XH, Xu B, Liu JT and Cui JR: Effect
of beta-escin sodium on endothelial cells proliferation, migration
and apoptosis. Vascul Pharmacol. 49:158–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kimura H, Ogawa S, Jisaka M, Kimura Y,
Katsube T and Yokota K: Identification of novel saponins from
edible seeds of Japanese horse chestnut (Aesculus turbinata BLUME)
after treatment with wooden ashes and their nutraceutical activity.
J Pharm Biomed Anal. 41:1657–1665. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu JN, Zhu XM, Han LK, Saito M, Sun YS,
Yoshikawa M, Kimura Y and Zheng YN: Anti-obesity effects of escins
extracted from the seeds of Aesculus turbinata BLUME
(Hippocastanaceae). Chem Pharm Bull. 56:12–16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marhuenda E, Alarcón de la Lastra C and
Martín MJ: Antisecretory and gastroprotective effects of aescine in
rats. Gen Pharmacol. 25:1213–1219. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang YW, Wang SJ, Zhou YN, Pan SH and Sun
B: Escin augments the efficacy of gemcitabine through
down-regulation of nuclear factor-κB and nuclear
factor-κB-regulated gene products in pancreatic cancer both in
vitro and in vivo. J Cancer Res Clin Oncol. 138:785–797. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Gao J, Cai X, Zhao Y, Wang Y, Lu
W, Gu Z, Zhang S and Cao P: Escin sodium induces apoptosis of human
acute leukemia Jurkat T cells. Phytother Res. 25:1747–1755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niu YP, Wu LM, Jiang YL, Wang WX and Li
LD: Beta-escin, a natural triterpenoid saponin from Chinese horse
chestnut seeds, depresses HL-60 human leukaemia cell proliferation
and induces apoptosis. J Pharm Pharmacol. 60:1213–1220. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niu YP, Li LD and Wu LM: Beta-aescin: A
potent natural inhibitor of proliferation and inducer of apoptosis
in human chronic myeloid leukemia K562 cells in vitro. Leuk
Lymphoma. 49:1384–1391. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen DY, Kang JH, Song W, Zhang WQ, Li WG,
Zhao Y and Chen QX: Apoptosis of human cholangiocarcinoma cell
lines induced by β-escin through mitochondrial caspase-dependent
pathway. Phytother Res. 25:1519–1526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou XY, Fu FH, Li Z, Dong QJ, He J and
Wang CH: Escin, a natural mixture of triterpene saponins, exhibits
antitumor activity against hepatocellular carcinoma. Planta Med.
75:1580–1585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Patlolla JM, Raju J, Swamy MV and Rao CV:
β-Escin inhibits colonic aberrant crypt foci formation in rats and
regulates the cell cycle growth by inducing p21waf1/cip1
in colon cancer cells. Mol Cancer Ther. 5:1459–1466. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia Z, Bergstrand A, DePierre JW and
Nässberger L: The antidepressants imipramine, clomipramine, and
citalopram induce apoptosis in human acute myeloid leukemia HL-60
cells via caspase-3 activation. J Biochem Mol Toxicol. 13:338–347.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bindokas VP, Jordán J, Lee CC and Miller
RJ: Superoxide production in rat hippocampal neurons: Selective
imaging with hydroethidine. J Neurosci. 16:1324–1336.
1996.PubMed/NCBI
|
|
30
|
Satoh T, Numakawa T, Abiru Y, Yamagata T,
Ishikawa Y, Enokido Y and Hatanaka H: Production of reactive oxygen
species and release of L-glutamate during superoxide anion-induced
cell death of cerebellar granule neurons. J Neurochem. 70:316–324.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan SY, Cheng CL, Ho HC, Wang SS, Chiu
KY, Su CK, Ou YC and Lin CC: Nortriptyline induces mitochondria and
death receptor-mediated apoptosis in bladder cancer cells and
inhibits bladder tumor growth in vivo. Eur J Pharmacol.
761:309–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wyllie AH, Kerr JF and Currie AR: Cell
death: The significance of apoptosis. Int Rev Cytol. 68:251–306.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu CS, Chen YJ, Chen JJ, Shieh JJ, Huang
CH, Lin PS, Chang GC, Chang JT and Lin CC: Terpinen-4-ol induces
apoptosis in human nonsmall cell lung cancer in vitro and in vivo.
Evid Based Complement Alternat Med. 2012:8182612012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng SB, Wu LC, Hsieh YC, Wu CH, Chan YJ,
Chang LH, Chang CM, Hsu SL, Teng CL and Wu CC: Supercritical carbon
dioxide extraction of aromatic turmerone from Curcuma longa Linn.
induces apoptosis through reactive oxygen species-triggered
intrinsic and extrinsic pathways in human hepatocellular carcinoma
HepG2 cells. J Agric Food Chem. 60:9620–9630. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Simon HU, Haj-Yehia A and Levi-Schaffer F:
Role of reactive oxygen species (ROS) in apoptosis induction.
Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Piao S, Kang M, Lee YJ, Choi WS, Chun YS,
Kwak C and Kim HH: Cytotoxic effects of escin on human
castration-resistant prostate cancer cells through the induction of
apoptosis and G2/M cell cycle arrest. Urology. 84:982.e1–982.e7.
2014. View Article : Google Scholar
|
|
38
|
Rimmon A, Vexler A, Berkovich L, Earon G,
Ron I and Lev-Ari S: Escin chemosensitizes human pancreatic cancer
cells and inhibits the nuclear factor-kappaB signaling pathway.
Biochem Res Int. 2013:2517522013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Küçükkurt I, Ince S, Keleş H, Akkol EK,
Avci G, Yeşilada E and Bacak E: Beneficial effects of Aesculus
hippocastanum L. seed extract on the body's own antioxidant defense
system on subacute administration. J Ethnopharmacol. 129:18–22.
2010. View Article : Google Scholar : PubMed/NCBI
|
